Valeant Pharmaceuticals said that effective December 31, 2008; the company completed its acquisition of Dow Pharmaceutical Sciences, a privately held dermatology company that specializes in the development of topical products on a proprietary basis, as well as for pharmaceutical and biotechnology companies.